Live Breaking News & Updates on Guggenheim Memorial Fellowship|Page 8

Stay updated with breaking news from Guggenheim memorial fellowship. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PVH (NYSE:PVH) PT Raised to $140.00 at Guggenheim

PVH (NYSE:PVH – Free Report) had its price objective increased by Guggenheim from $120.00 to $140.00 in a research report report published on Tuesday morning, Benzinga reports. The firm currently has a buy rating on the textile maker’s stock. Several other research firms also recently commented on PVH. TD Cowen lifted their price target on […] ....

United States , New Zealand General , New Zealand , Markd Fischer , Kapitalo Investimentos Ltda , Jpmorgan Chase Co , Quadrature Capital Ltd , Telsey Advisory Group , Tommy Hilfiger International , Goldman Sachs Group , Financial Services Group Inc , Wellington Management Group , Calvin Klein International , Securities Exchange Commission , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Investimentos Ltda , Capital Ltd , Services Group , Management Group , Teachers Retirement System , Retirement System , Tommy Hilfiger North America , Calvin Klein North America ,

ADC Therapeutics' (ADCT) "Buy" Rating Reiterated at Guggenheim

ADC Therapeutics (NYSE:ADCT – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Guggenheim in a research note issued on Friday, Benzinga reports. Other research analysts have also recently issued reports about the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price objective on shares of […] ....

United States , Millennium Management , America Corp , Royal Bank , Moneta Group Investment Advisors , Perceptive Advisors , Get Free Report , Group Investment Advisors , Adc Therapeutics , Nyse Adct , Reiterated Rating ,

ADC Therapeutics (NYSE:ADCT) Given Buy Rating at Guggenheim

ADC Therapeutics (NYSE:ADCT – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Guggenheim in a note issued to investors on Friday, Benzinga reports. Other equities research analysts have also recently issued reports about the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price objective on […] ....

United States , Therapeutics Company Profile , Royal Bank , Jpmorgan Chase Co , Moneta Group Investment Advisors , America Corp , Millennium Management , Redmile Group , Get Free Report , Group Investment Advisors , Adc Therapeutics , Nyse Adct , Reiterated Rating ,

Dutch Bros' (BROS) "Neutral" Rating Reiterated at Guggenheim

Dutch Bros (NYSE:BROS – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at Guggenheim in a research report issued on Friday, Benzinga reports. They currently have a $30.00 price target on the stock. Guggenheim’s price objective suggests a potential downside of 7.69% from the stock’s current price. Several other research firms have […] ....

United States , William Blair , Piper Sandler , Stifel Nicolaus , Brian Maxwell , Cedar Mountain Advisors , Dimensional Fund Advisors , A Management Llc , Dutch Bros Inc , Securities Exchange Commission , Jpmorgan Chase Co , Dutch Bros , Get Free Report , Exchange Commission , Mountain Advisors , Fund Advisors , Captrust Financial Advisors , Financial Advisors , Bros Inc , Company Operated Shops , Dutch Bros Coffee , Dutch Bros Rebel , Blue Rebel , Dutch Bros Daily , Nyse Bros , Consumer Staple ,